Request the following articles
R&D value measurement: Is R&D earning its investment?
Proof of concept is having a marked positive impact on performance
Externally sourced compounds are more likely to fail
Thomson Reuters Life Sciences Consulting provide biopharmaceutical companies with the powerful combination of consulting services, grounded in Thomson Reuters intelligent information assets for the Life Sciences industry, in-house developed analytical and data visualisation tools and the expertise of our industry consultants. Thomson Reuters Life Sciences Consulting provides information based consulting services across the areas of R&D, Clinical and Commercial Operations. By providing our clients with the right data, information and insights, grounded in Thomson Reuters intelligent information assets, we support our clients as they take informed actions to address their R&D, Clinical or Commercial Operations challenges.
Serving the biopharmaceutical industry, industry associations and academic institutions, we sit within the IP & Science division of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals.
Why work with us?
Thomson Reuters Life Sciences Consulting has access to an unrivalled array of data sources, from the long-standing CMR International global R&D and Clinical performance metrics databases to the wider assets of Thomson Reuters. This allows us to provide quantitative data and insight driven consultancy services unavailable elsewhere.
Our team of highly qualified R&D consultants bring depth of industry knowledge and experience to our engagements. Proprietary internally developed methodologies, bespoke data visualisation and analytics tools, and powerful modelling capabilities serve to set us apart.